Phase 2 Prostate Cancer (Adenocarcinoma) trials recruiting now

All Prostate Cancer (Adenocarcinoma) trials, every phase

Other phases for Prostate Cancer (Adenocarcinoma)

Phase 2 Prostate Cancer (Adenocarcinoma) trials

• 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
  NCT07209878 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
  NCT07332000 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 7 locations
• A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
  NCT06906471 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 90 Years · Sex: Male · 2 locations
• A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
  NCT06844383 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 8 locations
• FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
  NCT06636682 · Phase: Phase 2 · Ages: No age limits stated · Sex: Male · 3 locations
• Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
  NCT07182279 · Phase: Phase 1, Phase 2 · Ages: 40 Years and older · Sex: Male · 1 location
• PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer
  NCT07426055 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location
• Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
  NCT06957691 · Phase: Phase 2 · Ages: 40 Years and older · Sex: Male · 1 location
• Prostate Androgen Response Investigation Using a Stratification BIOmarker; Predicting Prostate Cancer Downstaging by Neoadjuvant Darolutamide With PCAI ImmunoScore
  NCT07617272 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)
  NCT07302451 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)
  NCT07179783 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
  NCT07745361 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 14 locations
• The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)
  NCT07038304 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer
  NCT07363382 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 90 Years · Sex: Male · 1 location
• Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
  NCT06616597 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.